Background
Methods
Results
Demographic data
Systemic features
Systemic risk factors
Source of infection
Source of infection | No. of patients | Percent |
---|---|---|
Infected catheter | 11 | 9.2 |
Urinary tract infection | 21 | 17.5 |
Hepatobiliary infection | 12 | 10.0 |
Lung infection | 19 | 15.8 |
Meningitis | 2 | 1.7 |
Infective endocarditis | 1 | 0.8 |
Gastrointestinal infection | 1 | 0.8 |
Genital infection | 2 | 1.7 |
Skin or soft tissue infection | 17 | 14.2 |
Septic arthritis | 1 | 0.8 |
Diabetic foot ulcer | 3 | 2.5 |
Nil | 30 | 25.0 |
Ocular features
Microbiology
Species | Blood (n = patient) | Other body fluids (n = patient) | Vitreous (n = eyes) |
---|---|---|---|
Culture positive | 50 (42.0%) | 46 (38.7%) | 27 (22.3%) |
Culture negative | 69 (58.0%) | 73 (61.3%) | 94 (77.7%) |
Gram-positive organism | 20 (40.0%) | 11 (23.9%) | 10 (37.0%) |
Staphylococcus aureas | 13 (26.0%) | 7 (15.2%) | 5 (18.5%) |
MRSA | 3 (6.0%) | 2 (4.3%) | 2 (7.4%) |
Staphylococcus coagulase -ve | 2 (4.0%) | 0 (0.0%) | 2 (7.4%) |
Streptococcus sp. | 2 (4.0%) | 2 (4.3%) | 1 (3.7%) |
Gram-negative organism | 26 (52.0%) | 28 (60.9%) | 12 (44.4%) |
Klebsiella pneumonia | 17 (34.0%) | 19 (41.3%) | 8 (29.6%) |
Pseudomonas aeruginosa | 2 (4.0%) | 4 (8.7%) | 3 (11.1%) |
Escherichia coli | 1 (2.0%) | 3 (6.5%) | 0 (0.0%) |
Acinebacter sp. | 1 (2.0%) | 2 (4.3%) | 0 (0.0%) |
Enterobacter intermedius | 1 (2.0%) | 0 (0.0%) | 0 (0.0%) |
Bukholderia cepacia | 1 (2.0%) | 0 (0.0%) | 1 (3.7%) |
Bukholderia pseudomallei | 1 (2.0%) | 0 (0.0%) | 0 (0.0%) |
Elizabethkingia meningosepticum | 1 (2.0%) | 0 (0.0%) | 0 (0.0%) |
Mycoplasma pneumonia | 1 (2.0%) | 0 (0.0%) | 0 (0.0%) |
Fungal | 4 (8.0%) | 7 (15.2%) | 5 (18.5%) |
Candida albicans | 1 (2.0%) | 5 (10.9%) | 1 (3.7%) |
Candida tropicalis | 2 (4.0%) | 1 (2.2%) | 0 (0.0%) |
Penicillium sp. | 0 (0.0%) | 0 (0.0%) | 2 (7.4%) |
Phanerochaeta chrysosporium | 0 (0.0%) | 0 (0.0%) | 1 (3.7%) |
Xylariaceae sp. | 0 (0.0%) | 0 (0.0%) | 1 (3.7%) |
Fungal (species not available) | 1 (2.0%) | 1 (2.2%) | 0 (0.0%) |
Number | Percent | |
---|---|---|
Gram-positive bacteria | 27 | 32.5 |
Staphylococcus aureas | 17 | 20.5 |
MRSA | 3 | 3.6 |
Staphylococcus coagulase -ve | 4 | 4.8 |
Streptococcus sp. | 3 | 3.6 |
Gram-negative bacteria | 42 | 50.6 |
Klebsiella pneumonia | 27 | 32.5 |
Pseudomonas aeruginosa | 5 | 6.0 |
Escherichia coli | 3 | 3.6 |
Acinebacter sp. | 2 | 2.4 |
Enterobacter intermedius | 1 | 1.2 |
Bukholderia cepacia | 1 | 1.2 |
Bukholderia pseudomallei | 1 | 1.2 |
Elizabethkingia meningosepticum | 1 | 1.2 |
Mycoplasma pneumonia | 1 | 1.2 |
Fungal | 14 | 16.9 |
Candida albicans | 5 | 6.0 |
Candida tropicalis | 3 | 3.6 |
Penicillium sp. | 2 | 2.4 |
Phanerochaeta chrysosporium | 1 | 1.2 |
Xylariaceae sp. | 1 | 1.2 |
Fungal (species not available) | 2 | 2.4 |
Treatment
Outcomes
Prognostic factor (referent) | Crude odds ratio (95% CI) | p valuea | Adjusted odds ratio (95% CI) | p valueb |
---|---|---|---|---|
Gender (male) | ||||
Female | 2 (0.92, 4.37) | 0.079 | ||
Age (0–50 years) | ||||
> 50 years | 0.85 (0.39, 1.86) | 0.679 | ||
Medical illness (yes) | ||||
No | 1.60 (0.55, 4.63) | 0.383 | ||
DM (yes) | ||||
No | 2.12 (0.93, 4.85) | 0.071 | ||
Presenting VA (≥ CF) | ||||
< CF | 0.10 (0.04, 0.25) | 0.000 | 0.09 (0.021, 0.384) | 0.001 |
Fundus view (yes) | ||||
No | 0.15 (0.06, 0.38) | 0.000 | 0.337 (0.068, 1.675) | 0.184 |
Source of infection (yes) | ||||
No | 2.61 (0.93, 7.37) | 0.062 | ||
Culture (positive) | ||||
Negative | 1.29 (0.54, 3.07) | 0.566 | ||
Organism (gram+) | ||||
Gram− | 0.965 (0.275–3.386) | 0.956 | ||
Fungal | 0.185 (0.019, 1.848) | 0.151 | ||
Intravitreal antibiotic (yes) | ||||
No | 2.85 (0.62, 13.2) | 0.234 | ||
Vitrectomy (yes) | ||||
No | 1.13 (0.53–2.41) | 0.751 | ||
Early vitrectomy (≤ 2 weeks) | ||||
> 2 weeks | 1.69 (0.59–4.82) | 0.327 |
Case | Age/sex/eye | Systemic risk factors | Initial VA | Culture | Organism | Source of infection | Systemic antibiotics/antifungal | IVT abk/antifungal | Vitrectomy | Final VA | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Blood | Other body fluids | Vitreous | ||||||||||
1 | 49/M/R | – | CF | + | + Sputum | − | Acinetobacter sp. | Skin infection | Ciprofloxacin | Yes | Yes | 6/18 |
2 | 76/F/R | – | PL | − | + Skin | − |
Candida albicans
| Skin infection | Fluconazole | Yes | Yes | NPL |
3 | 49/M/L | DM | 4/60 | − | + Skin | − |
Staphylococcus aureus
| Skin infection | Unasyn | Yes | No | 6/36 |
4 | 46/F/L | – | NAV | − | + Sputum | − | Acinetobacter sp. | Lung infection | Ceftriaxone, sulperazone | Yes | No | NAV |
5 | 39/F/L | Leukemia | 6/36 | − | − | − | – | – | Amphotericin, fluconazole | Yes | yes | 6/9 |
6 | 71/M/L | – | CF | + | − | − |
Klebsiella pneumonia
| UTI | Cefuroxime | Yes | No | 6/24 |
7 | 56/F/R | DM | NPL | − | − | − | – | Lung infection | Ciprofloxacin | Yes | No | NPL |
8 | 56/M/L | Leukemia | 6/60 | + | − | − |
Enterobacter intermedius
| – | Vancomycin, moxifloxacin | Yes | No | HM |
9 | 26/M/R | – | 6/36 | + | − | Not done |
Staphylococcus aureus
| IE | Cloxacillin, gentamicin | No | No | 6/36 |
10 | 26/M/L | – | 6/9 | + | − | Not done |
Staphylococcus aureus
| IE | Cloxacillin, gentamicin | No | No | 6/6 |
11 | 61/M/R | DM | CF | + | + Urine | − |
Candida albicans
| UTI | Fluconazole, voriconazole | Yes | Yes | 6/9 |
12 | 61/M/L | DM | 6/36 | + | + Urine | − |
Candida albicans
| UTI | Fluconazole, voriconazole | Yes | Yes | 6/9 |
13 | 60/M/R | DM | PL | − | + Liver, + sputum | − |
Klebsiella pneumonia
| HPB infection | Ciprofloxacin, cefuroxime, metronidazole | Yes | Yes | PL |
14 | 60/M/L | DM | PL | − | + Liver, + sputum | − |
Klebsiella pneumonia
| HPB infection | Ciprofloxacin, cefuroxime, metronidazole | Yes | No | NPL |
15 | 49/M/R | DM | HM | − | + Urine | − |
Staphylococcus aureus
| DFU | Ciprofloxacin | Yes | Yes | CF |
16 | 49/M/L | DM | HM | − | + Urine | − |
Staphylococcus aureus
| DFU | Ciprofloxacin | Yes | Yes | NPL |
17 | 52/F/L | DM | CF | − | − | − | – | – | Ciprofloxacin, vancomycin | Yes | No | CF |
18 | 57/M/L | DM, renal failure | CF | − | + Infected catheter | + |
Pseudomonas aeruginosa
| DFU | Ciprofloxacin, ceftazidime, meropenem | Yes | Yes | NPL |
19 | 38/F/L | DM | HM | − | − | − | – | HPB infection | Ciprofloxacin | Yes | Yes | HM |
20 | 71/F/R | DM | CF | + | − | − | Staphylococcus coagulase -ve | Lung infection | Cefuroxime | Yes | No | 6/60 |
21 | 49/F/L | Renal failure on steroid | CF | − | − | − | – | – | Fluconazole | Yes | Yes | 6/12 |
22 | 68/M/L | DM, malignancy | 6/12 | − | + Sputum | Not done |
Pseudomonas aeruginosa
| Lung infection | Ceftriaxone, cefuroxime | No | No | 6/9 |
23 | 56/M/L | DM, renal failure, hydronephrosis | 4/60 | + | − | − |
Staphylococcus aureus
| Infected catheter | Cloxacillin | Yes | No | 4/60 |
24 | 30/F/R | DM | PL | − | + Urine | + |
Klebsiella pneumonia
| UTI | Vancomycin, ceftazidime | Yes | Yes | PL |
25 | 65/F/R | – | 6/60 | − | − | − | – | UTI | NAV | Yes | Yes | 6/24 |
26 | 19/F/R | SLE with lupus nephritis, on steroid | 6/6 | + | − | − |
Staphylococcus aureus
| Infected catheter | Vancomycin | Yes | No | 6/18 |
27 | 75/F/R | DM | 6/18 | − | + Sputum | Not done |
Klebsiella pneumonia
| Lung infection | Ciprofloxacin | No | No | 6/24 |
28 | 75/F/L | DM | CF | − | + Sputum | − |
Klebsiella pneumonia
| Lung infection | Ciprofloxacin | Yes | Yes | PL |
29 | 51/F/R | DM | HM | − | + HVS | − |
Candida albicans
| – | Fluconazole | Yes | Yes | 6/9 |
30 | 53/F/L | – | HM | + | − | − |
Staphylococcus aureus
| – | Ciprofloxacin | Yes | Yes | CF |
31 | 49/M/L | DM | HM | NAV | NAV | − | NAV | HPB infection | NAV | Yes | Yes | CF |
32 | 19/M/R | – | HM | − | − | Not done | – | Meningitis | Ciprofloxacin | Yes | No | NAV |
33 | 65/F/L | CNS lymphoma | CF | − | − | − | – | – | Ciprofloxacin | Yes | Yes | CF |
34 | 77/M/R | – | CF | − | − | − | – | – | Ciprofloxacin, fluconazole | Yes | Yes | 6/36 |
35 | 27/F/R | – | 6/24 | − | − | Not done | – | Lung infection | NAV | No | No | 6/9 |
36 | 27/F/L | – | 6/24 | − | − | Not done | – | Lung infection | NAV | No | No | 6/9 |
37 | 56/F/R | – | 3/60 | + | − | Not done |
Staphylococcus aureus
| UTI | C-penicillin, unasyn | No | No | 6/9 |
38 | 62/M/R | DM | 6/12 | + | + Urine | Not done | Streptococcus sp. | UTI | Piperacillin-tazobactam | Yes | No | 6/9 |
39 | 62/M/L | DM | PL | + | + Urine | − | Streptococcus sp. | UTI | Piperacillin-tazobactam | Yes | No | 6/18 |
40 | 34/M/R | Renal failure | HM | − | + Urine | NAV |
Klebsiella pneumonia
| UTI | Sulperazone | Yes | No | 3/60 |
41 | 63/M/L | DM | CF | − | + Sputum | Not done |
Klebsiella pneumonia
| Lung infection | Trimethoprime, sulphamethoxazole | No | No | CF |
42 | 30/F/R | – | 6/60 | − | − | − | – | Skin infection | Cloxacillin | Yes | No | 6/6 |
43 | 30/F/L | – | 6/24 | − | − | Not done | – | Skin infection | Cloxacillin | Yes | No | 6/6 |
44 | 61/F/R | DM, sigmoid colon carcinoma | CF | − | − | − | – | Infected catheter | Ciprofloxacin, fluconazole | Yes | Yes | 6/36 |
45 | 40/M/L | – | HM | − | − | − | – | HPB infection | Ciprofloxacin, meropenem | Yes | Yes | NPL |
46 | 53/M/R | DM | HM | − | − | − | – | Lung infection | Cefoperazone | Yes | No | 6/60 |
47 | 53/M/L | DM | HM | − | − | − | – | Lung infection | Ceftriaxone | Yes | No | HM |
48 | 57/M/R | DM | HM | − | − | + |
Staphylococcus aureus
| UTI | Vancomycin | Yes | Yes | HM |
49 | 57/M/L | DM | 3/60 | − | − | + |
Staphylococcus aureus
| UTI | Vancomycin | Yes | Yes | NPL |
50 | 70/M/R | DM, hydronephrosis | HM | + | − | − |
Staphylococcus aureus
| Infected catheter | Cloxacillin, gentamicin | Yes | No | 6/18 |
51 | 70/M/L | DM, hydronephrosis | HM | + | − | − |
Staphylococcus aureus
| Infected catheter | Cloxacillin, gentamicin | Yes | No | CF |
52 | 19/M/L | Takayashu arteritis, renal failure on steroid | 2/60 | − | − | − | – | – | Ciprofoxacin, ceftazidime | Yes | No | 6/18 |
53 | 56/F/R | DM | 6/18 | + | + Liver | − |
Klebsiella pneumonia
| HPB infection | Cefuroxime | Yes | No | 6/18 |
54 | 56/M/R | DM | HM | + | − | − | MRSA | Infected catheter | Ciprofloxacin | Yes | No | CF |
55 | 56/M/L | DM | CF | + | − | − |
Klebsiella pneumonia
| Lung infection | Ceftazidime | Yes | No | NPL |
56 | 57/M/R | – | CF | − | − | − | – | – | Ciprofloxacin | Yes | No | 6/12 |
57 | 57/M/L | – | 6/12 | − | − | Not done | – | – | Ciprofloxacin | Yes | No | 6/12 |
58 | 38/F/L | – | 6/9 | − | + Urine | − |
Escherichia coli
| UTI | Ceftazidime | No | No | 6/9 |
59 | 55/M/R | DM | CF | − | + Infected catheter | − |
Staphylococcus aureus
| Skin infection | Ceftriaxone | Yes | No | CF |
60 | 7/M/R | Leukemia | 6/36 | − | + Infected catheter | − | Fungal* | Septic arthritis | Itraconazole | Yes | Yes | 6/9 |
61 | 42/F/R | – | CF | + | − | − |
Bukholderia pseudomallei
| – | Ciprofloxacin | Yes | No | 6/24 |
62 | 63/F/R | DM | NAV | + | + Urine/infected catheter | Not done |
Klebsiella pneumonia
| Skin infection | Ciprofloxacin | No | No | NPL |
63 | 71/F/L | – | HM | − | − | NAV | – | Lung infection | Ciprofloxacin | NAV | NAV | NAV |
64 | 22/F/L | Leukemia | 6/24 | + | − | Not done | Fungal* | – | Voriconazole | No | No | 6/18 |
65 | 45/M/L | DM, renal failure | NPL | + | + Infected catheter | − |
Staphylococcus aureus
| Infected catheter | Cloxacillin | Yes | No | NPL |
66 | 48/M/R | DM | CF | + | − | − |
Klebsiella pneumonia
| Lung infection | Ceftriaxone, amoxicillin-clavulanic acid | Yes | Yes | 6/60 |
67 | 31/M/L | – | CF | − | − | − | – | – | Ciprofloxacin | Yes | Yes | 6/6 |
68 | 54/M/L | – | 6/60 | + | + Sputum, CSF | + |
Klebsiella pneumonia
| Lung infection | Ceftriaxone, imipenem | Yes | No | NPL |
69 | 55/M/R | DM, renal failure | HM | + | + Infected catheter | − |
Staphylococcus aureus
| Skin infection | Ciprofloxacin | Yes | Yes | 6/60 |
70 | 55/M/L | DM, renal failure | HM | + | + Infected catheter | − |
Staphylococcus aureus
| Skin infection | Ciprofloxacin | Yes | Yes | 6/36 |
71 | 14/F/L | – | 6/36 | − | − | Not done | – | – | Ceftazidime, trimethoprime, sulphamethoxazole | No | No | 6/18 |
72 | 42/F/L | – | 6/60 | − | − | − | – | HPB infection | Ciprofloxacin, Ceftazidime | Yes | Yes | CF |
73 | 30/F/R | – | 6/12 | − | + HVS | − | Steroptococcus sp. | Genital infection | c-penicillin | Yes | No | 6/12 |
74 | 67/F/L | DM | HM | − | − | − | – | Lung infection | Ceftazidime | Yes | No | NAV |
75 | 65/M/L | – | CF | − | + Liver | − |
Klebsiella pneumonia
| HPB infection | Ciprofloxacin, imipenem | Yes | Yes | CF |
76 | 34/F/R | Leukemia | PL | + | − | − |
Candida tropicalis
| – | Voriconazole | Yes | No | NPL |
77 | 34/F/L | Leukemia | CF | + | − | − |
Candida tropicalis
| – | Voriconazole | Yes | Yes | 6/60 |
78 | 58/M/R | DM, renal failure | NPL | + | + Urine | + |
Pseudomonas aeruginosa
| UTI | Ciprofloxacin, metronidazole | No | No | NPL |
79 | 55/F/R | DM | 6/60 | + | − | + |
Bukholderia cepacia
| Meningitis | Ceftazidime | Yes | No | 6/36 |
80 | 25/M/L | – | PL | + | − | + | Steroptococcus sp. | – | Cloxacillin | Yes | Yes | NPL |
81 | 48/F/L | – | 6/60 | − | − | − | – | – | Ceftazidime | Yes | No | 6/18 |
82 | 52/F/L | DM | CF | + | + Urine | − |
Pseudomonas aeruginosa
| UTI | Ciprofloxacin | Yes | Yes | CF |
83 | 55/F/L | DM | HM | + | − | − |
Klebsiella pneumonia
| Lung infection | Amoxicillin-clavulanic acid, azithromycin | Yes | Yes | CF |
84 | 74/M/L | DM, renal carcinoma | CF | − | − | − | – | Skin infection | Ciprofloxacin, fluconazole | Yes | Yes | 6/24 |
85 | 37/F/R | DM | HM | + | − | − | – | Lung infection | Ciprofloxacin | Yes | Yes | 5/60 |
86 | 66/F/R | DM | PL | − | + Infected catheter | + |
Klebsiella pneumonia
| Skin infection | Ciprofloxacin | Yes | Yes | CF |
87 | 66/F/L | DM | PL | − | + Infected catheter | + |
Klebsiella pneumonia
| Skin infection | Ciprofloxacin | Yes | No | CF |
88 | 50/F/R | DM | HM | + | − | − | Staphylococcus coagulase -ve | UTI | Ciprofloxacin | Yes | No | 6/9 |
89 | 65/M/R | DM, alcoholic liver disease | CF | − | + Urine | − |
Candida albicans
| HPB infection | Fluconazole | Yes | Yes | CF |
90 | 65/M/L | DM, alcoholic liver disease | CF | − | + Urine | − |
Candida albicans
| HPB infection | Fluconazole | Yes | Yes | 3/60 |
91 | 49/F/L | DM | 6/9 | − | − | − | – | Skin infection | Ciprofloxacin, fluconazole | Yes | Yes | HM |
92 | 41/F/R | Leukemia | 6/7.5 | + | − | Not done |
Candida tropicalis
| – | Voriconazole | Yes | No | 6/9 |
93 | 41/F/L | Leukemia | 6/60 | + | − | − |
Candida tropicalis
| – | Voriconazole | Yes | No | 6/18 |
94 | 58/M/R | DM, liver disease | 6/36 | − | − | − | – | – | Ceftazidime | Yes | No | 6/9 |
95 | 55/F/R | Auto-immune hepatitis on steroid and immunosuppressant | CF | − | − | − | – | – | Ciprofloxacin | Yes | No | 6/12 |
96 | 81/M/R | – | HM | − | − | − | – | – | Ciprofloxacin | Yes | Yes | 6/12 |
97 | 32/F/R | Leukemia | 6/24 | − | − | + | Xylariaceae sp. | – | Voriconazole | Yes | Yes | CF |
98 | 32/F/L | Leukemia | 6/12 | − | − | − | – | – | Voriconazole | Yes | Yes | 6/12 |
99 | 63/F/R | – | HM | − | − | + | Staphylococcus coagulase -ve | Skin infection | Ciprofloxacin | Yes | Yes | 6/9 |
100 | 54/M/L | DM, renal failure | PL | + | + Infected catheter | + |
Staphylococcus aureus
| Infected catheter | Ciprofloxacin, amoxicillin-clavulanic acid | Yes | No | NPL |
101 | 46/F/R | DM | HM | − | − | + | Penicillium sp. | – | Amphotericin, fluconazole | Yes | Yes | CF |
102 | 64/M/L | DM, rectal carcinoma | PL | − | − | − | – | – | Ciprofloxacin | Yes | Yes | HM |
103 | 66/M/L | DM | 6/24 | + | − | + |
Mycoplasma pneumonia
| Lung infection | Ciprofloxacin, azithromycin | Yes | Yes | 6/9 |
104 | 59/F/L | DM, renal failure | HM | − | − | − | – | – | Ciprofloxacin | Yes | Yes | CF |
105 | 70/M/R | DM | PL | − | − | + | Penicillium sp. | – | Itraconazole | Yes | Yes | 6/36 |
106 | 41/F/R | DM | HM | − | − | − | – | Lung infection | Ciprofloxacin | Yes | Yes | PL |
107 | 67/M/L | DM | 6/9 | + | + Urine | + | Escherichia coli | UTI | Ciprofloxacin | Yes | Yes | CF |
108 | 63/M/R | – | 1/60 | + | + Infected catheter | + | MRSA | Skin infection | Vancomycin, ciprofloxacin | Yes | Yes | 6/9 |
109 | 63/M/L | – | 6/24 | + | + Infected catheter | Not done | MRSA | Skin infection | Vancomycin, ciprofloxacin | No | No | 6/12 |
110 | 52/M/L | DM, renal failure | HM | − | − | + |
Phanerochaete chrysosporium
| Skin infection | Voriconazole | Yes | No | CF |
111 | 45/M/R | DM, renal failure | PL | + | − | − |
Staphylococcus aureus
| Infected catheter | Cloxacillin | Yes | Yes | NPL |
112 | 47/M/R | Alcoholic liver disease on steroid | 6/12 | + | − | Not done |
Staphylococcus aureus
| Skin infection | Cloxacillin | No | No | 6/9 |
113 | 47/M/L | Alcoholic liver disease on steroid | 6/12 | + | − | Not done |
Staphylococcus aureus
| Skin infection | Cloxacillin | No | No | 6/9 |
114 | 58/M/L | DM | PL | + | + Infected catheter | + | MRSA | Genital infection | Ciprofloxacin | Yes | Yes | HM |
115 | 67/F/R | – | 6/36 | − | + Urine | + |
Klebsiella pneumonia
| UTI | Cefuroxime | Yes | Yes | CF |
116 | 48/M/L | DM | HM | − | − | Not done | – | Skin infection | Ciprofloxacin | Yes | Yes | 6/18 |
117 | 78/F/L | – | CF | − | − | + | Staphylococcus coagulase -ve | – | Ciprofloxacin, ceftazidime | Yes | Yes | 3/60 |
118 | 61/F/L | DM | PL | − | + Urine | − |
Klebsiella pneumonia
| UTI | Ciprofloxacin, meropenem | Yes | Yes | CF |
119 | 55/F/L | DM | 3/60 | + | + Sputum | − |
Klebsiella pneumonia
| Lung infection | Ceftazidime | Yes | Yes | 6/12 |
120 | 55/M/L | – | PL | + | − | + |
Klebsiella pneumonia
| HPB infection | Ceftriaxone, ciprofloxacin, metronidazole | Yes | No | NPL |
121 | 60/M/R | DM | PL | + | + Infected catheter | + |
Staphylococcus aureus
| Skin infection | Cloxacillin, ceftazidime | Yes | No | HM |
122 | 60/M/L | DM | PL | + | + Infected catheter | + |
Staphylococcus aureus
| Skin infection | Cloxacillin, ceftazidime | Yes | Yes | HM |
123 | 40/F/R | DM/liver cirrhosis, myelodysplastic syndrome | 6/18 | + | + Infected catheter | − |
Klebsiella pneumonia
| Lung infection | Cefuroxime, piperacillin-tazobactam | Yes | Yes | CF |
124 | 32/F/L | DM | 6/60 | + | − | − |
Klebsiella pneumonia
| UTI | Cefuroxime | Yes | No | 6/12 |
125 | 34/F/L | DM | HM | − | + Urine | + |
Candida albicans
| – | Amphoterin | Yes | Yes | 6/18 |
126 | 57/F/R | DM | PL | + | − | − |
Klebsiella pneumonia
| AGE | Ciprofloxacin | Yes | Yes | NAV |
127 | 48/M/R | DM | PL | − | − | − | – | DFU | Ciprofloxacin, Ceftazidime | Yes | No | NPL |
128 | 65/F/R | DM | 1/60 | − | + Urine | − |
Klebsiella pneumonia
| UTI | Ciprofloxacin | Yes | No | 6/60 |
129 | 65/F/R | DM, renal failure | HM | − | − | − | – | – | Ciprofloxacin | Yes | Yes | CF |
130 | 72/F/L | DM | HM | − | + Urine | − |
Escherichia coli
| UTI | Ciprofloxacin, trimethoprime, sulphamethoxazole | Yes | No | NPL |
131 | 55/F/R | DM | HM | + | − | − |
Klebsiella pneumonia
| HPB infection | Ceftriaxone | Yes | Yes | HM |
132 | 67/M/R | Adenocarcinoma of lung and colon | HM | − | − | − | – | Infected catheter | Fluconazole, voriconazole | Yes | Yes | NPL |
133 | 68/F/L | DM, renal failure | CF | + | − | − |
Elizabethkingia meningocepticum
| Infected catheter | Ceftazidime, cefazolin, vancomycin | Yes | No | CF |
134 | 68/F/R | DM, renal failure | 6/24 | + | − | − |
Elizabethkingia meningocepticum
| Infected catheter | Ceftazidime, cefazolin, vancomycin | Yes | No | 6/12 |
135 | 61/F/L | DM, renal failure | HM | + | − | − |
Staphylococcus aureus
| Infected catheter | Cloxacillin | Yes | No | 6/36 |
136 | 44/M/L | DM | PL | + | + Liver | + |
Klebsiella pneumonia
| HPB infection | Ceftazidime, imipenem | Yes | No | NPL |
137 | 65/M/L | DM, chronic cystitis | CF | − | + Urine | − |
Klebsiella pneumonia
| UTI | Ciprofloxacin | Yes | Yes | CF |
138 | 59/F/L | DM, renal Failure | HM | − | − | − | – | Skin infection | Ciprofloxacin | Yes | Yes | 6/18 |
139 | 67/F/L | Hepatolithiasis | PL | + | + Liver | − |
Klebsiella pneumonia
| HPB infection | Ciprofloxacin, imipenem | Yes | No | NPL |
140 | 76/M/R | DM | CF | − | + Urine | − |
Candida albicans
| UTI | Fluconazole | Yes | Yes | 6/9 |
141 | 76/M/L | DM | CF | − | + Urine | − |
Candida albicans
| UTI | Fluconazole | Yes | Yes | 6/24 |
142 | 38/F/R | – | HM | − | − | + |
Pseudomonas aeruginosa
| – | Ceftriaxone, ciprofloxacin, metronidazole | Yes | Yes | HM |
143 | 69/M/L | DM | HM | + | + Urine | + |
Klebsiella pneumonia
| UTI | Cefepime, amoxicillin-clavulanic acid | Yes | Yes | 1/60 |